|
1
|
Roth GA, Mensah GA, Johnson CO, Addolorato
G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ,
Benziger CP, et al: Global burden of cardiovascular diseases and
risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll
Cardiol. 76:2982–3021. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cho YS, Moon SC, Ryu KS and Ryu KH: A
study on clinical and healthcare recommending service based on
cardiovascula disease pattern analysis. Int J Biosci Biotechnol.
8:287–294. 2016.
|
|
3
|
Nalban N, Sangaraju R, Alavala S, Mir SM,
Jerald MK and Sistla R: Arbutin attenuates isoproterenol-induced
cardiac hypertrophy by inhibiting TLR-4/NF-κB pathway in mice.
Cardiovasc Toxicol. 20:235–248. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Roth GA, Mensah GA and Fuster V: The
global burden of cardiovascular diseases and risks: A compass for
global action. J Am Coll Cardiol. 76:2980–2981. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oh T, Kim D, Lee S, Won C, Kim S, Yang JS,
Yu J, Kim B and Lee J: Machine learning-based diagnosis and risk
factor analysis of cardiocerebrovascular disease based on KNHANES.
Sci Rep. 12:22502022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Leong DP, Joseph PG, McKee M, Anand SS,
Teo KK, Schwalm JD and Yusuf S: Reducing the global burden of
cardiovascular disease, part 2: Prevention and treatment of
cardiovascular disease. Circ Res. 121:695–710. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Van Camp G: Cardiovascular disease
prevention. Acta Clin Belg. 69:407–411. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao Y, Jia WW, Ren S, Xiao W, Li GW, Jin
L and Lin Y: Difluoromethylornithine attenuates
isoproterenol-induced cardiac hypertrophy by regulating apoptosis,
autophagy and the mitochondria-associated membranes pathway. Exp
Ther Med. 22:8702021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gallo S, Vitacolonna A, Bonzano A,
Comoglio P and Crepaldi T: ERK: A key player in the pathophysiology
of cardiac hypertrophy. Int J Mol Sci. 20:21642019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ellison GM, Waring CD, Vicinanza C and
Torella D: Physiological cardiac remodelling in response to
endurance exercise training: Cellular and molecular mechanisms.
Heart. 98:5–10. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Selvetella G, Hirsch E, Notte A, Tarone G
and Lembo G: Adaptive and maladaptive hypertrophic pathways: Points
of convergence and divergence. Cardiovasc Res. 63:373–380. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shimizu I and Minamino T: Physiological
and pathological cardiac hypertrophy. J Mol Cell Cardiol.
97:245–262. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kurosawa Y, Kojima K, Kato M, Ohashi R,
Minami K and Narita H: Protective action of angiotensin converting
enzyme inhibitors on cardiac hypertrophy in the aortic-banded rat.
Jpn Heart J. 40:645–654. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
A Romero C, Mathew S, Wasinski B, Reed B,
Brody A, Dawood R, Twiner MJ, McNaughton CD, Fridman R, Flack JM,
et al: Angiotensin-converting enzyme inhibitors increase
anti-fibrotic biomarkers in African Americans with left ventricular
hypertrophy. J Clin Hypertens (Greenwich). 23:1008–1016. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Y, Shen HJ, Wang XQ, Liu HQ, Zheng LY
and Luo JD: EndophilinA2 protects against angiotensin II-induced
cardiac hypertrophy by inhibiting angiotensin II type 1 receptor
trafficking in neonatal rat cardiomyocytes. J Cell Biochem.
119:8290–8303. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Walsh-Wilkinson É, Drolet MC, Le Houillier
C, Roy ÈM, Arsenault M and Couet J: Sex differences in the response
to angiotensin II receptor blockade in a rat model of eccentric
cardiac hypertrophy. PeerJ. 7:e74612019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang CS, Tsai PJ, Sung JM, Chen JY, Ho
LC, Pandya K, Maeda N and Tsai YS: Diuretics prevent
thiazolidinedione-induced cardiac hypertrophy without compromising
insulin-sensitizing effects in mice. Am J Pathol. 184:442–453.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Okura T, Miyoshi K, Irita J, Enomoto D,
Jotoku M, Nagao T, Watanabe K, Matsuokan H, Ashihara T, Higaki J,
et al: Comparison of the effect of combination therapy with an
angiotensin II receptor blocker and either a low-dose diuretic or
calcium channel blocker on cardiac hypertrophy in patients with
hypertension. Clin Exp Hypertens. 35:563–569. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang X, Zhang MC and Wang CT: Loss of
LRRC25 accelerates pathological cardiac hypertrophy through
promoting fibrosis and inflammation regulated by TGF-β1. Biochem
Biophys Res Commun. 506:137–144. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zang Y, Wan J, Zhang Z, Huang S, Liu X and
Zhang W: An updated role of astragaloside IV in heart failure.
Biomed Pharmacother. 126:1100122020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma Y, Kang R and Liu X: Research progress
in prevention and cure of fibrosis by traditional Chinese medicine.
Mod Appl Sci. 2:127–132. 2008. View Article : Google Scholar
|
|
22
|
Yang QY, Chen KJ, Lu S and Sun HR:
Research progress on mechanism of action of Radix Astragalus in the
treatment of heart failure. Chin J Integr Med. 18:235–240. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karmazyn M and Gan XT: Treatment of the
cardiac hypertrophic response and heart failure with ginseng,
ginsenosides, and ginseng-related products. Can J Physiol
Pharmacol. 95:1170–1176. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang J, Wang HX, Zhang YJ, Yang YH, Lu ML,
Zhang J, Li ST, Zhang SP and Li G: Astragaloside IV attenuates
inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway
in isoproterenol-induced myocardial hypertrophy. J Ethnopharmacol.
150:1062–1070. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu ZH, Liu HB and Wang J: Astragaloside
IV protects against the pathological cardiac hypertrophy in mice.
Biomed Pharmacother. 97:1468–1478. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo J, Gan XT, Haist JV, Rajapurohitam V,
Zeidan A, Faruq NS and Karmazyn M: Ginseng inhibits cardiomyocyte
hypertrophy and heart failure via NHE-1 inhibition and attenuation
of calcineurin activation. Circ Heart Fail. 4:79–88. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qin N, Gong QH, Wei LW, Wu Q and Huang XN:
Total ginsenosides inhibit the right ventricular hypertrophy
induced by monocrotaline in rats. Biol Pharm Bull. 31:1530–1535.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bu L, Dai O, Zhou F, Liu F, Chen JF, Peng
C and Xiong L: Traditional Chinese medicine formulas, extracts, and
compounds promote angiogenesis. Biomed Pharmacother.
132:1108552020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Luo J, Xu H and Chen K: Systematic review
of compound danshen dropping pill: A chinese patent medicine for
acute myocardial infarction. Evid Based Complement Alternat Med.
2013:8080762013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tu Y: Artemisinin-A gift from traditional
Chinese medicine to the world (nobel lecture). Angew Chem Int Ed
Engl. 55:10210–10226. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang R, Yuan BC, Ma YS, Zhou S and Liu Y:
The anti-inflammatory activity of licorice, a widely used Chinese
herb. Pharm Biol. 55:5–18. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mu F, Duan J, Bian H, Zhai X, Shang P, Lin
R, Zhao M, Hu D, Yin Y, Wen A and Xi M: Metabonomic strategy for
the evaluation of Chinese medicine Salvia miltiorrhiza and
Dalbergia odorifera interfering with myocardial
ischemia/reperfusion injury in rats. Rejuvenation Res. 20:263–277.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang S, Zhang S, Wang S, Gao P and Dai L:
A comprehensive review on Pueraria: Insights on its
chemistry and medicinal value. Biomed Pharmacother. 131:1107342020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hou N, Huang Y, Cai SA, Yuan WC, Li LR,
Liu XW, Zhao GJ, Qiu XX, Li AQ, Cheng CF, et al: Puerarin
ameliorated pressure overload-induced cardiac hypertrophy in
ovariectomized rats through activation of the PPARα/PGC-1 pathway.
Acta Pharmacol Sin. 42:55–67. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yuan G, Shi S, Jia Q, Shi J, Shi S, Zhang
X, Shou X, Zhu X and Hu Y: Use of network pharmacology to explore
the mechanism of Gegen (Puerariae lobatae Radix) in the
treatment of type 2 diabetes mellitus associated with
hyperlipidemia. Evid Based Complement Alternat Med.
2021:66334022021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou YX, Zhang H and Peng C: Puerarin: A
review of pharmacological effects. Phytother Res. 28:961–975. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu J, Zhang HJ, Ji BP, Cai SB, Wang RJ,
Zhou F, Yang JS and Liu HJ: A diet formula of Puerariae radix,
Lycium barbarum, Crataegus pinnatifida, and Polygonati rhizoma
alleviates insulin resistance and hepatic steatosis in CD-1 mice
and HepG2 cells. Food Funct. 5:1038–1049. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu B, Wu Z, Li Y, Ou C, Huang Z, Zhang J,
Liu P, Luo C and Chen M: Puerarin prevents cardiac hypertrophy
induced by pressure overload through activation of autophagy.
Biochem Biophys Res Commun. 464:908–915. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gao W, Guo N, Zhao S, Chen Z, Zhang W, Yan
F, Liao H and Chi K: Carboxypeptidase A4 promotes cardiomyocyte
hypertrophy through activating PI3K-AKT-mTOR signaling. Biosci Rep.
40:BSR202006692020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Foulquier S, Daskalopoulos EP, Lluri G,
Hermans KCM, Deb A and Blankesteijn WM: WNT signaling in cardiac
and vascular disease. Pharmacol Rev. 70:68–141. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Weeks KL, Bernardo BC, Ooi JYY, Patterson
NL and McMullen JR: The IGF1-PI3K-Akt signaling pathway in
mediating exercise-induced cardiac hypertrophy and protection. Adv
Exp Med Biol. 1000:187–210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fan J, Qiu L, Shu H, Ma B, Hagenmueller M,
Riffel JH, Meryer S, Zhang M, Hardt SE, Wang L, et al: Recombinant
frizzled1 protein attenuated cardiac hypertrophy after myocardial
infarction via the canonical Wnt signaling pathway. Oncotarget.
9:3069–3080. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lieven O, Knobloch J and Rüther U: The
regulation of Dkk1 expression during embryonic development. Dev
Biol. 340:256–268. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li Y, Lu W, King TD, Liu CC, Bijur GN and
Bu G: Dkk1 stabilizes Wnt co-receptor LRP6: Implication for Wnt
ligand-induced LRP6 down-regulation. PLoS One. 5:e110142010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang T, Duan YM, Fu Q, Liu T, Yu JC, Sui
ZY, Huang L and Wen GQ: IM-12 activates the Wnt-β-catenin signaling
pathway and attenuates rtPA-induced hemorrhagic transformation in
rats after acute ischemic stroke. Biochem Cell Biol. 97:702–708.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cheng Y, Shen A, Wu X, Shen Z, Chen X, Li
J, Liu L, Lin X, Wu M, Chen Y, et al: Qingda granule attenuates
angiotensin II-induced cardiac hypertrophy and apoptosis and
modulates the PI3K/AKT pathway. Biomed Pharmacother.
133:1110222021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Guo Y, Yu ZY, Wu J, Gong H, Kesteven S,
Iismaa SE, Chan AY, Holman S, Pinto S, Pironet A, et al: The
Ca2+-activated cation channel TRPM4 is a positive
regulator of pressure overload-induced cardiac hypertrophy. Elife.
10:e665822021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Schnelle M, Chong M, Zoccarato A, Elkenani
M, Sawyer GJ, Hasenfuss G, Ludwig C and Shah AM: In vivo
[U-13C]glucose labeling to assess heart metabolism in
murine models of pressure and volume overload. Am J Physiol Heart
Circ Physiol. 319:H422–H431. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ma X, Song Y, Chen C, Fu Y, Shen Q, Li Z
and Zhang Y: Distinct actions of intermittent and sustained
β-adrenoceptor stimulation on cardiac remodeling. Sci China Life
Sci. 54:493–501. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ribeiro DA, Buttros JB, Oshima C,
Bergamaschi CT and Campos RR: Ascorbic acid prevents acute
myocardial infarction induced by isoproterenol in rats: Role of
inducible nitric oxide synthase production. J Mol Histol.
40:99–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Prabhu S, Narayan S and Devi CS: Mechanism
of protective action of mangiferin on suppression of inflammatory
response and lysosomal instability in rat model of myocardial
infarction. Phytother Res. 23:756–760. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Xu H, Wang Z, Chen M, Zhao W, Tao T, Ma L,
Ni Y and Li W: YTHDF2 alleviates cardiac hypertrophy via regulating
Myh7 mRNA decoy. Cell Biosci. 11:1322021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhang GX, Kimura S, Murao K, Yu X, Obata
K, Matsuyoshi H and Takaki M: Effects of angiotensin type I
receptor blockade on the cardiac Raf/MEK/ERK cascade activated via
adrenergic receptors. J Pharmacol Sci. 113:224–233. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Li L, Cai H, Liu H and Guo T: β-Adrenergic
stimulation activates protein kinase Cε and induces extracellular
signal-regulated kinase phosphorylation and cardiomyocyte
hypertrophy. Mol Med Rep. 11:4373–4380. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Werhahn SM, Kreusser JS, Hagenmüller M,
Beckendorf J, Diemert N, Hoffmann S, Schultz JH, Backs J and
Dewenter M: Adaptive versus maladaptive cardiac remodelling in
response to sustained β-adrenergic stimulation in a new ‘ISO on/off
model’. PLoS One. 16:e02489332021. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Garg M and Khanna D: Exploration of
pharmacological interventions to prevent isoproterenol-induced
myocardial infarction in experimental models. Ther Adv Cardiovasc
Dis. 8:155–169. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Liu BY, Li L, Liu GL, Ding W, Chang WG, Xu
T, Ji XY, Zheng XX, Zhang J and Wang JX: Baicalein attenuates
cardiac hypertrophy in mice via suppressing oxidative stress and
activating autophagy in cardiomyocytes. Acta Pharmacol Sin.
42:701–714. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wen J, Shen J, Zhou Y, Zhao X, Dai Z and
Jin Y: Pyrroloquinoline quinone attenuates isoproterenol
hydrochloride-induced cardiac hypertrophy in AC16 cells by
inhibiting the NF-κB signaling pathway. Int J Mol Med. 45:873–885.
2020.PubMed/NCBI
|
|
60
|
Zhao Y, Jiang Y, Chen Y, Zhang F, Zhang X,
Zhu L and Yao X: Dissection of mechanisms of Chinese medicinal
formula Si-Miao-Yong-an decoction protects against cardiac
hypertrophy and fibrosis in isoprenaline-induced heart failure. J
Ethnopharmacol. 248:1120502020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang C, Wang Y, Ge Z, Lin J, Liu J, Yuan
X and Lin Z: GDF11 attenuated ANG II-induced hypertrophic
cardiomyopathy and expression of ANP, BNP and beta-MHC through
down-regulating CCL11 in mice. Curr Mol Med. 18:661–671. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Cameron VA, Rademaker MT, Ellmers LJ,
Espiner EA, Nicholls MG and Richards AM: Atrial (ANP) and brain
natriuretic peptide (BNP) expression after myocardial infarction in
sheep: ANP is synthesized by fibroblasts infiltrating the infarct.
Endocrinology. 141:4690–4697. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Edwards JG: Cardiac MHC gene expression:
More complexity and a step forward. Am J Physiol Heart Circ
Physiol. 294:H14–H15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yuan Y, Zong J, Zhou H, Bian ZY, Deng W,
Dai J, Gan HW, Yang Z, Li H and Tang QZ: Puerarin attenuates
pressure overload-induced cardiac hypertrophy. J Cardiol. 63:73–81.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yeh YL, Tsai HI, Cheng SM, Pai P, Ho TJ,
Chen RJ, Lai CH, Huang PJ, Padma VV and Huang CY: Mechanism of
Taiwan Mingjian Oolong tea to inhibit isoproterenol-induced
hypertrophy and apoptosis in cardiomyoblasts. Am J Chin Med.
44:77–86. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Guan XH, Hong X, Zhao N, Liu XH, Xiao YF,
Chen TT, Deng LB, Wang XL, Wang JB, Ji GJ, et al: CD38 promotes
angiotensin II-induced cardiac hypertrophy. J Cell Mol Med.
21:1492–1502. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Hu H, Jiang M, Cao Y, Zhang Z, Jiang B,
Tian F, Feng J, Dou Y, Gorospe M, Zheng M, et al: HuR regulates
phospholamban expression in isoproterenol-induced cardiac
remodelling. Cardiovasc Res. 116:944–955. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Huo S, Shi W, Ma H, Yan D, Luo P, Guo J,
Li C, Lin J, Zhang C, Li S, et al: Alleviation of inflammation and
oxidative stress in pressure overload-induced cardiac remodeling
and heart failure via IL-6/STAT3 inhibition by raloxifene. Oxid Med
Cell Longev. 2021:66990542021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Bi X, Zhang Y, Yu Y, Yuan J, Xu S, Liu F,
Ye J and Liu P: MiRNA-339-5p promotes isoproterenol-induced
cardiomyocyte hypertrophy by targeting VCP to activate the mTOR
signaling. Cell Biol Int. 46:288–299. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Han B, Xu J, Shi X, Zheng Z, Shi F, Jiang
F and Han J: DL-3-n-butylphthalide attenuates myocardial
hypertrophy by targeting gasdermin D and inhibiting gasdermin D
mediated inflammation. Front Pharmacol. 12:6881402021. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Shah AK, Bhullar SK, Elimban V and Dhalla
NS: Oxidative stress as a mechanism for functional alterations in
cardiac hypertrophy and heart failure. Antioxidants (Basel).
10:9312021. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Gai Z, Wang Y, Tian L, Gong G and Zhao J:
Whole genome level analysis of the Wnt and DIX gene families in
mice and their coordination relationship in regulating cardiac
hypertrophy. Front Genet. 12:6089362021. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Qin H, Zhang Y, Wang R, Du X, Li L and Du
H: Puerarin suppresses Na+-K+-ATPase-mediated systemic inflammation
and CD36 expression, and alleviates cardiac lipotoxicity in vitro
and in vivo. J Cardiovasc Pharmacol. 68:465–472. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Moon RT, Kohn AD, De Ferrari GV and Kaykas
A: WNT and beta-catenin signalling: Diseases and therapies. Nat Rev
Genet. 5:691–701. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Agostino M and Pohl SÖ: The structural
biology of canonical Wnt signalling. Biochem Soc Trans.
48:1765–1780. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Hua Y, Yang Y, Li Q, He X, Zhu W, Wang J
and Gan X: Oligomerization of Frizzled and LRP5/6 protein initiates
intracellular signaling for the canonical WNT/β-catenin pathway. J
Biol Chem. 293:19710–19724. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Gao C and Chen YG: Dishevelled: The hub of
Wnt signaling. Cell Signal. 22:717–727. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Zeng KW, Wang JK, Wang LC, Guo Q, Liu TT,
Wang FJ, Feng N, Zhang XW, Liao LX, Zhao MM, et al: Small molecule
induces mitochondrial fusion for neuroprotection via targeting CK2
without affecting its conventional kinase activity. Signal
Transduct Target Ther. 6:712021. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Ríos JA, Godoy JA and Inestrosa NC: Wnt3a
ligand facilitates autophagy in hippocampal neurons by modulating a
novel GSK-3β-AMPK axis. Cell Commun Signal. 16:152018. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Barker N, Morin PJ and Clevers H: The
Yin-Yang of TCF/beta-catenin signaling. Adv Cancer Res. 77:1–24.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Piazza F, Manni S, Tubi LQ, Montini B,
Pavan L, Colpo A, Gnoato M, Cabrelle A, Adami F, Zambello R, et al:
Glycogen synthase kinase-3 regulates multiple myeloma cell growth
and bortezomib-induced cell death. BMC Cancer. 10:5262010.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Guo Y, Gupte M, Umbarkar P, Singh AP, Sui
JY, Force T and Lal H: Entanglement of GSK-3β, β-catenin and TGF-β1
signaling network to regulate myocardial fibrosis. J Mol Cell
Cardiol. 110:109–120. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Guan X, He Y, Wei Z, Shi C, Li Y, Zhao R,
Pan L, Han Y, Hou T and Yang J: Crosstalk between Wnt/β-catenin
signaling and NF-κB signaling contributes to apical periodontitis.
Int Immunopharmacol. 98:1078432021. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Jia D, Yang W, Li L, Liu H, Tan Y, Ooi S,
Chi L, Filion LG, Figeys D and Wang L: β-Catenin and NF-κB
co-activation triggered by TLR3 stimulation facilitates stem
cell-like phenotypes in breast cancer. Cell Death Differ.
22:298–310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Shang S, Hua F and Hu ZW: The regulation
of β-catenin activity and function in cancer: Therapeutic
opportunities. Oncotarget. 8:33972–33989. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Gitau SC, Li X, Zhao D, Guo Z, Liang H,
Qian M, Lv L, Li T, Xu B, Wang Z, et al: Acetyl salicylic acid
attenuates cardiac hypertrophy through Wnt signaling. Front Med.
9:444–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Olsen NT, Dimaano VL, Fritz-Hansen T,
Sogaard P, Chakir K, Eskesen K, Steenbergen C, Kass DA and Abraham
TP: Hypertrophy signaling pathways in experimental chronic aortic
regurgitation. J Cardiovasc Transl Res. 6:852–860. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Liu JJ, Shentu LM, Ma N, Wang LY, Zhang
GM, Sun Y, Wang Y, Li J and Mu YL: Inhibition of NF-κB and
Wnt/β-catenin/GSK3β signaling pathways ameliorates cardiomyocyte
hypertrophy and fibrosis in streptozotocin (STZ)-induced type 1
diabetic rats. Curr Med Sci. 40:35–47. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Ou L, Fang L, Tang H, Qiao H, Zhang X and
Wang Z: Dickkopf Wnt signaling pathway inhibitor 1 regulates the
differentiation of mouse embryonic stem cells in vitro and
in vivo. Mol Med Rep. 13:720–730. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Kim S, Song G, Lee T, Kim M, Kim J, Kwon
H, Kim J, Jeong W, Lee U, Na C, et al: PARsylated transcription
factor EB (TFEB) regulates the expression of a subset of Wnt target
genes by forming a complex with β-catenin-TCF/LEF1. Cell Death
Differ. 28:2555–2570. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Zhang L, Guo Z, Wang Y, Geng J and Han S:
The protective effect of kaempferol on heart via the regulation of
Nrf2, NF-κβ, and PI3K/Akt/GSK-3β signaling pathways in
isoproterenol-induced heart failure in diabetic rats. Drug Dev Res.
80:294–309. 2019. View Article : Google Scholar : PubMed/NCBI
|
